📈
Price Transparency
Compare your plan's per-claim costs against CMS NADAC benchmarks in real time. Identify PBM spread pricing where your plan pays 20-40% above what pharmacies actually pay for drugs.
Instantly compare your plan's drug costs against federal NADAC benchmarks to uncover PBM spread pricing.
Built for HR leaders, benefits consultants, and pharmacy plan sponsors.
| Drug | NADAC / Unit | Your Price | Spread | Est. Annual |
|---|
Click any drug to see its full profile — all formulations, price ranges, and employer context. Powered by CMS NADAC acquisition cost data.
Ozempic, Wegovy, and Mounjaro are among the fastest-growing pharmacy cost drivers. Here's what CMS NADAC data shows for acquisition costs.
Your PBM controls the data. We give you federal benchmarks to level the playing field.
Compare your plan's per-claim costs against CMS NADAC benchmarks in real time. Identify PBM spread pricing where your plan pays 20-40% above what pharmacies actually pay for drugs.
Track FDA approvals, patent cliff timelines, and biosimilar entries that directly affect your formulary costs. Upcoming patent expirations on drugs like Eliquis and Keytruda represent major savings opportunities.
Use NADAC data to model contract renegotiation scenarios with your PBM. Benchmark pricing guarantees against federal acquisition costs — not inflated AWP or WAC spread.
Live headlines from FDA, pharma industry, and regulatory sources.
Common questions about NADAC, PBM contracts, biosimilars, and pharmacy plan management.